Effect of 2-CDA on thrombocytopenia in myelofibrosis.
N
N
Abramson
A R
AR
Marks
D017338:Cladribine / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D055728:Primary Myelofibrosis / Q000188:drug therapy*; D013921:Thrombocytopenia / Q000150:complications*
D007166:Immunosuppressive Agents; D017338:Cladribine